Research-Treatment

Research-Treatment

An update on FVII gene therapy and more.
The goal of the study is to collect useful data that can improve lives.
With the rapid rise in antibiotic-resistant bacteria, doctors aren’t eager to hand you a prescription anymore.
Researchers plan to use these tests to work with blood banks to help protect the blood supply.
FDA approves new drugs for VWD, hemophilia A and HIV-1
Two women’s experiences with factor X deficiency.
This discovery has implications for future gene therapy experiments.
“I wish my son just had plain old hemophilia again,” a mother of one of my inhibitor patients said.
Updates on Daklinza, Technivie, and the ACE910 trial
Coagadex is the first FX concentrate available.
An array of new medications to treat HCV hit the market.
NHF is committed to the training and support of clinician-researchers in hematology.
Chat Icon
Need Information about Bleeding Disorders?
Contact The Neil Frick Resource Center (NFRC)